Aspirin in Colorectal Cancer Liver Metastases
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Colorectal Cancer
- Colorectal Cancer Liver Metastases
- Liver Metastases
- Type
- Interventional
- Phase
- Phase 2Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Multi-centre, double-blinded, randomized, placebo-controlled clinical intervention trial.Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: Eligible patients will be allocated in a 1:1 ratio using a computer randomization procedure stratified by centre. The randomization will be blocked within each stratum.Primary Purpose: Prevention
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03326791
- Collaborators
- Norwegian Cancer Society
- The Research Council of Norway
- Klinbeforsk
- Investigators
- Principal Investigator: Bjørn A Bjørnbeth, MD PhD Oslo University Hospital Principal Investigator: Kjetil Taskèn, MD PhD University of Oslo Principal Investigator: Sheraz Yaqub, MD PhD Oslo University Hospital